Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
A "humanized" immune system rodent model is one in which human primary haematopoietic cells and tissues are implanted into an immunodeficient host that generate a functional human immune system. Humanized mice or rat model are commonly used as small animal models in biological and medical research for human therapeutics.
Growth in this market can primarily be attributed to factors such as the growing demand of personalized medicine, continuous support in the form of investments and grants from the government and private sectors, increasing number of R&D activities in pharmaceutical and biotechnology companies, and the increasing number of research activities involving humanized models. Increasing production of monoclonal antibodies and rising demand for humanized rat models are expected to provide a wide range of growth opportunities for players in the market.
The global Humanized Mouse and Rat Model market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Humanized Mouse and Rat Model volume and value at global level, regional level and company level. From a global perspective, this report represents overall Humanized Mouse and Rat Model market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Humanized Mouse and Rat Model in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Humanized Mouse and Rat Model manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
The Jackson Laboratory (US)
Taconic Biosciences (US)
Horizon Discovery Group(UK)
genOway (France)
Charles River Laboratories (US)
Harbour Antibodies BV (China)
Hera BioLabs (US)
Vitalstar Biotechnology Co (China)
inGenious Targeting Laboratory (US)
AXENIS(France)
Crown Bioscience (US)
Transgenic (Japan)
Champions Oncology (US)
Horizon Discovery Group(UK)
Hera BioLabs (US)
Yecuris Corporation (US)
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Genetic
Cell-Based
Segment by Application
Pharmaceutical
Biotechnology Companies
CRO
Growth in this market can primarily be attributed to factors such as the growing demand of personalized medicine, continuous support in the form of investments and grants from the government and private sectors, increasing number of R&D activities in pharmaceutical and biotechnology companies, and the increasing number of research activities involving humanized models. Increasing production of monoclonal antibodies and rising demand for humanized rat models are expected to provide a wide range of growth opportunities for players in the market.
The global Humanized Mouse and Rat Model market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Humanized Mouse and Rat Model volume and value at global level, regional level and company level. From a global perspective, this report represents overall Humanized Mouse and Rat Model market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Humanized Mouse and Rat Model in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Humanized Mouse and Rat Model manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
The Jackson Laboratory (US)
Taconic Biosciences (US)
Horizon Discovery Group(UK)
genOway (France)
Charles River Laboratories (US)
Harbour Antibodies BV (China)
Hera BioLabs (US)
Vitalstar Biotechnology Co (China)
inGenious Targeting Laboratory (US)
AXENIS(France)
Crown Bioscience (US)
Transgenic (Japan)
Champions Oncology (US)
Horizon Discovery Group(UK)
Hera BioLabs (US)
Yecuris Corporation (US)
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Genetic
Cell-Based
Segment by Application
Pharmaceutical
Biotechnology Companies
CRO
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
